Home / Import refusals / AEK-2587483-3/11/1

FDA Import Refusal AEK-2587483-3/11/1 — Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company

Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company — FEI 2650089

The FDA refused shipment AEK-2587483-3/11/1 from Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company (United States) on January 12, 2023. The refused product falls under Drugs and Biologics — APIXABAN (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
January 12, 2023
Country
United States
Product Category
Drugs and Biologics
Product Code
61LCE44 APIXABAN (ANTI-COAGULANT)
Charges
75

Recent inspections

  • 1147009 (VAI Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1110480 (VAI Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079769 (OAI Wed Feb 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030016 (VAI Mon Sep 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 986929 (NAI Wed May 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • AEK-6628512-0/11/1 (Fri Jan 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • UPS-7478587-5/11/1 (Fri Mar 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • UPS-7478583-4/11/1 (Fri Mar 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • UPS-7500704-8/11/1 (Mon Mar 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • UPS-7459643-9/11/1 (Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources